ICD 10 CM E26.89 | Description & Clinical Information
ICD 10 E26.89 describes a medical condition characterized by an excessive amount of aldosterone in the bloodstream that cannot be classified under any other code, where aldosterone is a hormone produced by the adrenal glands that plays a crucial role in regulating water and sodium retention as well as potassium excretion, and this code is used when the healthcare provider documents a type of hyperaldosteronism that is not represented by any other code.
Official Description Of E26.89
The ICD 10 CM book defines ICD 10 code E26.89 as:
When To Use E26.89
The diagnosis describes by the ICD-10-CM E26.89 code is hyperaldosteronism, a condition in which the adrenal gland produces too much aldosterone hormone, leading to various health problems. The hormone aldosterone regulates the balance of electrolytes, including sodium and potassium, within the body. When aldosterone levels are increased, sodium reabsorption is increased, resulting in water retention and decreased levels of potassium, leading to high blood pressure or hypertension.
Hyperaldosteronism can have two types: primary and secondary. Primary hyperaldosteronism occurs when one or both adrenal glands produce too much aldosterone. On the other hand, secondary hyperaldosteronism occurs when the renin-angiotensin-aldosterone system (RAAS) is overactive, leading to increased aldosterone levels.
Patients with hyperaldosteronism may experience various symptoms, including headaches, blurred vision, flushing, excessive sweating, excessive urination, excessive thirst, strokes, and heart and kidney complications. Providers diagnose the disease based on the patient’s medical history, physical examination, and signs and symptoms. Diagnostic tests for hyperaldosteronism include blood tests for potassium, aldosterone, and renin levels, aldosterone-to-renin ratio, 24-hour urine test for aldosterone, and 18-hydroxycorticosterone to rule out an aldosterone-producing tumor. Some providers may also use captopril, saline, or dexamethasone suppression tests to diagnose the condition. Additionally, imaging tests such as magnetic resonance imaging (MRI), scintigraphy, or computed tomography (CT) of the adrenal glands may be conducted to locate any tumors.
If the provider finds a tumor in the adrenal gland, they will proceed with surgery to remove it. The procedure is known as adrenalectomy. However, if both glands are involved, providers may prescribe aldosterone antagonist medications that stop aldosterone action to treat the condition. These medications help prevent sodium reabsorption and increase potassium retention.
Patients with hyperaldosteronism may also be advised to restrict their sodium intake and eat foods containing potassium. Doing so can help regulate their blood pressure and prevent fluid retention. In some cases, medications such as spironolactone (an aldosterone antagonist), potassium-sparing diuretics, and antihypertensives may be used to relieve symptoms.
In conclusion, hyperaldosteronism is a condition that can cause several health complications. Therefore, it is essential to diagnose the disease early and seek appropriate medical attention. By doing so, patients can manage their condition and avoid severe complications.
